Truvestments Capital’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39K Hold
360
– – ﹤0.01% 1036
2026
Q1
$1.42K Hold
360
– – ﹤0.01% 1027
2025
Q4
$2.44K Hold
360
– – ﹤0.01% 874
2025
Q3
$2.51K Hold
360
– – ﹤0.01% 906
2025
Q2
$2.2K Hold
360
– – ﹤0.01% 830
2025
Q1
$2.74K Hold
360
– – ﹤0.01% 828
2024
Q4
$3.46K Hold
360
– – ﹤0.01% 753
2024
Q3
$2.13K Buy
+360
New +$2.38K ﹤0.01% 789
2024
Q2
– Sell
-360
Closed -$2.77K – 493
2024
Q1
$2.77K Hold
360
– – ﹤0.01% 591
2023
Q4
$3.16K Hold
360
– – ﹤0.01% 645
2023
Q3
$2.62K Hold
360
– – ﹤0.01% 570
2023
Q2
$2.38K Hold
360
– – ﹤0.01% 592
2023
Q1
$1.23K Sell
360
-806
-69% -$3.12K ﹤0.01% 599
2022
Q4
$3.24K Hold
1,166
– – ﹤0.01% 632
2022
Q3
$3K Hold
1,166
– – ﹤0.01% 517
2022
Q2
$4K Buy
+1,166
New +$4.57K ﹤0.01% 503
2022
Q1
– Sell
-643
Closed -$4K – 389
2021
Q4
$4K Hold
643
– – ﹤0.01% 506
2021
Q3
$4K Hold
643
– – ﹤0.01% 477
2021
Q2
$8K Hold
643
– – ﹤0.01% 413
2021
Q1
$7K Sell
643
-174
-21% -$1.68K ﹤0.01% 486
2020
Q4
$7K Buy
+817
New +$5.88K ﹤0.01% 464
2018
Q3
$14K Buy
+2,191
New +$9.9K 0.01% 581

Other funds holding MDXG

Truvestments Capital's MDXG Position: Q2 2026 in Review

Truvestments Capital held its MiMedx Group (MDXG) position steady in Q2 2026 at 360 shares worth $1.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Truvestments Capital first reported a position in MDXG in Q3 2018 and has held it in 22 quarters since. The position peaked at $14K in Q3 2018. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Truvestments Capital held 360 shares of MiMedx Group worth $1.39K as of Q2 2026.
  • Truvestments Capital left its MiMedx Group share count unchanged in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #1036 holding.
  • Truvestments Capital first reported a position in MiMedx Group in Q3 2018 and has held it in 22 quarters since.
  • Truvestments Capital's MiMedx Group position peaked at $14K in Q3 2018.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.